Business Wire

TRADITIONDATA

10.10.2022 13:43:42 CEST | Business Wire | Pressemeddelelse

Del
TraditionDATA lancerer ny skandinavisk datapakke

TraditionDATA, data- og informationsserviceafdelingen hos Compagnie Financière Tradition (Tradition), har udgivet en omfattende skandinavisk datapakke som svar på den stigende efterspørgsel på Traditions markedsførende prisdata i regionen.

Den fulde pakke af skandinaviske data, som indeholder data om valuta (FX), rentederivater (IRD) og inflation, er baseret på en kombination af priser, der tager udgangspunkt i aktiehandler foretaget af Traditions markedsførende mæglere samt deres ekspertanalyser. Dataene er tilgængelige direkte fra TraditionDATA såvel som på Refinitiv under firmaets regionale markedsdatapakker.

Udgivelsen af den skandinaviske datapakke er i tråd med TraditionDATAs mission om at tilbyde mindre, granulære pakker baseret på valuta, region eller produkt, som gør det muligt for kunderne kun at betale for det, de rent faktisk har brug for. Dette er i direkte modsætning til mange af deres konkurrenter, som kun tilbyder større europæiske pakker, som er dyre og tager tid at analysere nærmere, før de kan konverteres til brugbar forretningsindsigt.

Den skandinaviske datapakke giver kunderne mulighed for at analysere:

  • FX - spothandler, krydshandler (cross trades), terminshandler på ydelser og produkter og kvartalsindtjening på tværs af DKK, NOK og SEK på det internationale valutamarked
  • IRD - basisderivater, krydsvalutaderivater, renteswaps, overnight indexed swaps, terminskursaftaler
  • Inflation - forbrugerprisindeksdata om inflation

Udover at tilbyde kunderne avancerede data og ekspertise i den skandinaviske region, muliggør TraditionDATA også streaming i realtid, øjebliksbilleder af dag til dag-renter, adgang til historiske data og fuld integration med eksisterende arbejdsgange.

James Watson, Global Head of Sales hos TraditionDATA, kommenterede: “Hos TraditionDATA ved vi, at der ikke findes to ens virksomheder, og derfor arbejder vi sammen med vores kunder om at udvikle pakker, der er skræddersyede til deres individuelle behov. Vi tror på, at regionale markeder fortsat vil kræve specifikke datasæt, der er lokaliseret til deres overordnede forretningsaktiviteter, og denne tilgang har allerede vist sig at være en stor succes i forbindelse med vores japanske Nihon- og israelske Shekel-pakker. Vi ser frem til at fortsætte med at tilføje nye instrumenter til den skandinaviske pakke og udvide vores regionale markedsdatatilbud i de kommende måneder.”

ENDS

Om TraditionDATA

TraditionDATA tilbyder en varieret og fleksibel tilgang til leverance af markedsdata på tværs af alle aktivklasser på det globale uofficielle børsmarked for derivater.

Ved at tilbyde mindre, mere fokuserede og granulære pakker baseret på valuta, region eller produkt sætter TraditionDATA sine kunder i stand til at betale for netop det, de har brug for, i modsætning til større pakker, der kræver nærmere analyse.

Med over 1 billion datapunkter på tværs af mere end 200 produkter og 186.000 instrumenter, der går mere end 15 år tilbage, samt 43 kontorer i 30 lande, tilbyder TraditionDATA aktører på tværs af det globale finansmarked alle de oplysninger, de har brug for, for at drive deres forretning og tage forretningsmæssige beslutninger, på grundlag af et stadigt voksende datasæt.

TraditionDATA er en del af Tradition (Compagnie Financière Tradition S.A. (SWX: CFT)), en af verdens største børsmæglere inden for finansielle og råvarerelaterede produkter på det uofficielle børsmarked for værdipapirer. Traditions lange historie med administration af prissætning af likviditet og afvikling af handler på tværs af flere aktivklasser med både nye og komplekse produkter på primære og nye vækstmarkeder gør det muligt for TraditionDATA at prisfastsætte finansielle instrumenter på mange af verdens mest omskiftelige markeder, som andre ikke formår.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

For at se dette indhold fra cts.businesswire.com, så skal du give din accept på toppen af denne side.

Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20221010005055/da/

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis7.5.2026 14:50:00 CEST | Press release

First presentation of Week 24 results from TRuE-AD4 study in adults with moderate atopic dermatitis (AD) who had an inadequate response, intolerance or contraindication to topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs)at the 2026 EADV SymposiumThe vast majority of patients achieving EASI50 at Week 8 and continuing double-blind, as needed treatment with Opzelura® (ruxolitinib) cream through Week 24 demonstrated disease control, with 84.3% achieving EASI75 (a ≥75% improvement in the Eczema Area and Severity Index score from baseline) and 70.6% achieving IGA-TS (Investigator’s Global Assessment Treatment Success)Data support Type-II variation application submitted for ruxolitinib cream 1.5% for the treatment of adults with moderate AD in the European Union (EU), feedback expected in 1H 2026 Incyte (Nasdaq:INCY) today announced final 24-week data from the Phase 3 TRuE-AD4 study evaluating the efficacy and safety of Opzelura® (ruxolitinib) cream in adults with mode

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release

Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release

“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release

Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye